Conditions: Overactive Bladder
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 855
Healthy volunteers: no

Brief summary:
With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers. Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive bladder a disease characterized by a collection of symptoms, including urinary frequency, urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol through the skin into the bloodstream.

Detailed description:

Arms:
arm 1: Subjects decided to purchase Oxytrol.

Interventions: intervention 1: Oxybutynin (Oxytrol, BAY839380)
Intervention descriptions: intervention 1: Oxybutynin transdermal patch, 3.9 mg daily (Oxytrol Transdermal System)

Protocol document: